 Patients will have received a haplo-identical stem cell transplant on our on-going study CD45 YTH-24 and YTH-54 and CD52 Campath 1H Monoclonal Antibody Conditioning Regimen for Allogeneic Donor Stem Cell Transplantation of Patients with Fanconi Anemia H-9938 IND 7233 and will become eligible to receive allodepleted T Cells following engraftment. What follows is a summary of the treatment plan including initial transplant phase as well as generation and infusion of allodepleted T cells. 